These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 9312126
1. Analysis of factor XIII substrate specificity using recombinant human factor XIII and tissue transglutaminase chimeras. Hettasch JM, Peoples KA, Greenberg CS. J Biol Chem; 1997 Oct 03; 272(40):25149-56. PubMed ID: 9312126 [Abstract] [Full Text] [Related]
5. Purification and characterization of recombinant human coagulant factor XIII A-chains expressed in E. coli. Lai TS, Santiago MA, Achyuthan KE, Greenberg CS. Protein Expr Purif; 1994 Apr 03; 5(2):125-32. PubMed ID: 7914444 [Abstract] [Full Text] [Related]
10. Probing interactions between the coagulants thrombin, Factor XIII, and fibrin(ogen). Maurer MC, Trumbo TA, Isetti G, Turner BT. Arch Biochem Biophys; 2006 Jan 01; 445(1):36-45. PubMed ID: 16364233 [Abstract] [Full Text] [Related]
11. Analysis of the catalytic activity of human factor XIIIa by site-directed mutagenesis. Hettasch JM, Greenberg CS. J Biol Chem; 1994 Nov 11; 269(45):28309-13. PubMed ID: 7961769 [Abstract] [Full Text] [Related]
12. The role of β-barrels 1 and 2 in the enzymatic activity of factor XIII A-subunit. Hethershaw EL, Adamson PJ, Smith KA, Goldsberry WN, Pease RJ, Radford SE, Grant PJ, Ariëns RAS, Maurer MC, Philippou H. J Thromb Haemost; 2018 Jul 11; 16(7):1391-1401. PubMed ID: 29675848 [Abstract] [Full Text] [Related]
15. Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture. Jadhav MA, Goldsberry WN, Zink SE, Lamb KN, Simmons KE, Riposo CM, Anokhin BA, Maurer MC. Biochim Biophys Acta Proteins Proteom; 2017 Oct 11; 1865(10):1246-1254. PubMed ID: 28687225 [Abstract] [Full Text] [Related]
16. Tissue transglutaminase, coagulation factor XIII, and the pro-polypeptide of von Willebrand factor are all ligands for the integrins alpha 9beta 1 and alpha 4beta 1. Takahashi H, Isobe T, Horibe S, Takagi J, Yokosaki Y, Sheppard D, Saito Y. J Biol Chem; 2000 Aug 04; 275(31):23589-95. PubMed ID: 10816592 [Abstract] [Full Text] [Related]
17. The activation peptide of coagulation factor XIII is vital for its expression and stability. Handrkova H, Schroeder V, Kohler HP. J Thromb Haemost; 2015 Aug 04; 13(8):1449-58. PubMed ID: 26083359 [Abstract] [Full Text] [Related]
18. Inhibition of factor XIII activation by an anti-peptide monoclonal antibody. Lukacova D, Matsueda GR, Haber E, Reed GL. Biochemistry; 1991 Oct 22; 30(42):10164-70. PubMed ID: 1681898 [Abstract] [Full Text] [Related]
19. Cross-linking of plasminogen activator inhibitor 2 and alpha 2-antiplasmin to fibrin(ogen). Ritchie H, Lawrie LC, Crombie PW, Mosesson MW, Booth NA. J Biol Chem; 2000 Aug 11; 275(32):24915-20. PubMed ID: 10816585 [Abstract] [Full Text] [Related]
20. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Ariëns RA, Philippou H, Nagaswami C, Weisel JW, Lane DA, Grant PJ. Blood; 2000 Aug 01; 96(3):988-95. PubMed ID: 10910914 [Abstract] [Full Text] [Related] Page: [Next] [New Search]